Biocon Invest Information

Biocon Establishes Strategic Licensing and Supply Agreement with Tabuk Pharmaceutical Sep 27, 2024

Biocon Subsidiary Signs Deal for Biosimilar Distribution in Global Markets Aug 30, 2024